Archives

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
Novel Human Genetics Evidence Confirms Estimates of Genetic Prevalence, Underdiagnosis, and Potentially Greater Symptom Burden of Gain-of-Function CASR Variants Associated with ADH1
Market Updates

Novel Human Genetics Evidence Confirms Estimates of Genetic Prevalence, Underdiagnosis, and Potentially Greater Symptom Burden of Gain-of-Function CASR Variants Associated with ADH1

- By examining over 100 unique variants associated with the CASR gene causative of ADH1, the average frequency of gain-of-function CASR variants was ~3.7 per 100,000, closely aligned to previously pub...

  • July 23, 2025 04:30 AM PDT
  • EODHD
EU prepares €100B tariff retaliation if Trump imposes 30% duties
Economy

EU prepares €100B tariff retaliation if Trump imposes 30% duties

The European Union is readying a sweeping €100 billion ($117 billion) package of retaliatory tariffs on American goods if President Donald Trump follows through on his threat to impose a 30% levy on most EU exports after August 1, as per a Bloomberg report. In the absence of a deal, the EU would combine an […]

  • July 23, 2025 04:25 AM PDT
  • Invezz
Earnings Snapshot: Otis Worldwide trims FY net sales outlook after Q2 revenue miss
Market Updates

Earnings Snapshot: Otis Worldwide trims FY net sales outlook after Q2 revenue miss

[ ] Seeking Alpha MORE ON OTIS WORLDWIDE * Otis Worldwide Q2 Preview: Anticipating Weak Equipment Sales [https://seekingalpha.com/article/4800462-otis-worldwide-q2-preview-anticipating-weak-equipment-...

  • July 23, 2025 04:21 AM PDT
  • EODHD
Abivax's ulcerative colitis drug meets primary goals in Phase 3 trials; shares jump 400%
Market Updates

Abivax's ulcerative colitis drug meets primary goals in Phase 3 trials; shares jump 400%

Investing.com -- Abivax shares rose over 400% in Paris on Wednesday after the French biotech company announced that its lead drug candidate obefazimod achieved primary endpoints in two Phase 3 clinica...

  • July 23, 2025 04:21 AM PDT
  • EODHD
No plans to get Big Tech to pay digital law compliance costs, EU tech chief says
Market Updates

No plans to get Big Tech to pay digital law compliance costs, EU tech chief says

By Foo Yun Chee BRUSSELS (Reuters) -The European Commission will not ask Alphabet, Amazon, Apple, ByteDance, Meta Platforms and Microsoft to pay the cost of monitoring their compliance with a new digi...

  • July 23, 2025 04:20 AM PDT
  • EODHD
AT&T subscriber additions top estimates as group notes savings from new tax law
Market Updates

AT&T subscriber additions top estimates as group notes savings from new tax law

Investing.com - AT&T posted better-than-anticipated wireless subscriber additions in the second quarter on Wednesday, as the telecoms group pushes to entice customers with options that bundle high-spe...

  • July 23, 2025 04:18 AM PDT
  • EODHD
TE Connectivity Stock Jumps. Earnings Show That Managing Tariffs Can Be Easy.
Market Updates

TE Connectivity Stock Jumps. Earnings Show That Managing Tariffs Can Be Easy.

TE Connectivity reports fiscal third-quarter earnings per share of $2.27 from sales of $4.5 billion, topping Wall Street estimates on both metrics. Continue Reading View Comments

  • July 23, 2025 04:17 AM PDT
  • EODHD
AT&T Stock Slips Despite an Earnings Beat. Why Investors Were Looking for More.
Market Updates

AT&T Stock Slips Despite an Earnings Beat. Why Investors Were Looking for More.

AT&T stock was a touch lower on Wednesday, even though the wireless carrier topped Wall Street’s earnings expectations. Investors may have been looking for perfection after rival Verizon Communication...

  • July 23, 2025 04:17 AM PDT
  • EODHD
VIP Play finance chief to step down
Market Updates

VIP Play finance chief to step down

* VIP Play (OTCPK:VIPZ [https://seekingalpha.com/symbol/VIPZ]) said that [https://seekingalpha.com/pr/20174708-vip-play-inc-announces-departure-of-chief-financial-officer] Jim Mackey, the company's CF...

  • July 23, 2025 04:13 AM PDT
  • EODHD
Oatly revenue rises as Europe growth offsets North America weakness
Market Updates

Oatly revenue rises as Europe growth offsets North America weakness

MALMÖ, Sweden - Oatly Group AB (NASDAQ:OTLY) reported second quarter revenue of $208.4 million, up 3.0% compared to the same period last year, as strong performance in Europe offset weakness in North...

  • July 23, 2025 04:12 AM PDT
  • EODHD